Type A botulinum toxin was studied for its ability to inhibit the action of acetylcholinesterase. The chromogenic substrate, indophenyl acetate, was used for assay ofenzyme activity. Inhibition ofenzyme function was detected through use ofboth 6.6 X 10-6 mg (20 LDS0) and 6.6 x I010 mg (2 x 10-3 LD50) of type A botulinal toxin. Control assays were performed by use of both homologous antitoxin and heterologous antitoxins (types B and E). Enzyme inhibition was effectively prevented by use ofhomologous antitoxin only. The inhibition noted was specific and reproducible for given substrate, enzyme, and toxin concentrations.
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Various techniques have been investigated for detection of botulinal toxin in foods, biological materials, and other vehicles in search for a specific, rapid, and sensitive test for each of the five common serotypes of this toxin. Early work has been summarized in a recent review on botulism (8) . The best of the early methods was the mouse toxicity test, for which specific antitoxin was used to establish the toxin serotype by immune-protection control tests, but this procedure was slow, despite its sensitivity and specificity. In more recent research, the discovery of hemagglutination of certain kinds of erythrocytes by toxin-containing preparations (6) seemed to interested workers in this area to be a possible approach until Lamanna and Lowenthal (7) demonstrated that hemagglutinin activity and botulinal toxin activity were not associated in a single molecule. Boroff (1, 2) Mouse LD6o assay of type A botulinal toxin. The crystalline toxin was reconstituted and diluted for use in 0.9% NaCl. Ten albino mice, weighing 20 to 22 g each, were injected intraperitoneally with 0.1 ml of each dilution of botulinal toxin. Number of deaths was recorded at the end of 4 days, and LD5o values were determined by the method of Weiss (10) after three replications of the entire assay had been performed.
In vitro acetylcholinesterase assay. The acetylcholinesterase stock solution was prepared by diluting the purified enzyme preparation in Clark and Lubs buffer (4) a Final volume, 3.0 ml per cuvette. b Difference in the OD of the cuvette without toxin and the cuvette with toxin or with toxin and antitoxin, as specified.
c Concentration of Ac'ase was 5.0 pg/ml unless otherwise specified; toxin and enzyme were incubated for 10 min prior to IPA addition except where noted.
d Toxin and antitoxin were incubated for 10 min prior to addition of enzyme except where noted. e Toxin and Ac'ase were incubated for 30 min at 25 C before being added to the reaction mixture.
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There was a definite and reproducible inhibition of acetylcholinesterase activity by the botulinal toxin appearing as a difference in OD values in test versus control readings over the time interval specified (Table 1) . Indeed, the standard slopes of the dose-response curves, obtained directly, were significantly different. The inhibition by the toxin was presumably due to a binding with, or a masking of, either or both the active combining site and the specificity site on the enzyme molecule. The addition of homologous antitoxin completely reversed this action and prevented all enzyme inhibition at both toxin concentrations used. Absolute specificity of the enzyme inhibition by the toxin was revealed through the ineffectiveness in blocking toxin activity by heterologous antitoxins at either toxin concentration and through the reversal of inhibition by addition of homologous antitoxin. In fact, the serological cross-reaction observed by Lamanna and Lowenthal (7) between type A toxin and type B antitoxin obviously did not occur in this system. Although acetylcholinesterase inhibition is reproducible and constant for given toxin, enzyme, and substrate concentrations, enzyme inhibition is never complete. Concentration gradients of each of the compounds in the reaction mixture will be run to determine whether complete inhibition can be achieved with a sufficiently large dose of toxin and whether decreased levels of inhibition can be achieved with more dilute toxin preparations.
It was found, in this regard, that the difference in OD (amount of inhibition of the enzyme by the toxin) could be increased by increasing the toxin concentration while keeping the enzyme and substrate concentrations constant, or by decreasing the enzyme concentration and increasing the incubation time. Also, when toxin A and enzyme were incubated for 10 min prior to the addition of antitoxin A and when this mixture was then incubated for 10 min before IPA addition, a total reversal of enzyme inhibition was obtained. However, when toxin A and enzyme were incubated for 30 min prior to the addition of antitoxin A and when this mixture was then incubated for an additional 10 min before addition of IPA, an incomplete enzyme inhibition was obtained; i.e., about half the OD difference was observed, relative to that in the toxin-enzyme system incubated for only 10 min. From these data, we speculate that there may be an action of acetylcholinesterase on the toxin such that release of small toxic, but not antigenic, fragments occurs. According to this speculation, there would be partial inhibition of enzyme activity by fragments not binding to antitoxin and whose concentration would be related to the time of incubation or of exposure of toxin to the acetylcholinesterase molecule. Our data indicate that some system, perhaps not the one above, is causing a potentiation of toxicity such that the amount of an antitoxin required for neutralization is no longer sufficient to prevent enzyme inhibition. Further work will be done to characterize this system.
